Anticancer activity of ferrocenylthiosemicarbazones


Por: Sandra, CM, Elena K., Marcos, FA, Elena, MK, Arturo, RR, Teresa R.A., Marcos M.-G.

Publicada: 1 mar 2014
Resumen:
Aliphatic and aromatic ferrocenylthiosemicarbazones were synthesized. The characterization of the new ferrocenylthio-semicarbazones was done by IR, 1H-NMR and 13C-NMR spectroscopy, elemental analysis and X-ray diffraction studies. The biological activity of the obtained compounds was assessed in terms of anticancer activity. Their activity against U251 (human glyoblastoma), PC-3 (human prostatic adenocarcinoma), K562 (human chronic myelogenous leukemia), HCT-15 (human colorectal adenocarcinoma), MCF-7 (human mammary adenocarcinoma) and SKLU-1 (human lung adenocarcinoma) cell lines was studied and compared with cisplatin. All tested compounds showed good activity and the aryl-chloro substituted ferrocenylthiosemicarbazones showed the best anticancer activity. © 2014 Bentham Science Publishers.

Filiaciones:
Sandra, CM:
 Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico

Elena K.:
 Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico

Marcos, FA:
 Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico

Arturo, RR:
 Univ Nacl Autonoma Mexico, Inst Quim, Mexico City 04510, DF, Mexico

Teresa R.A.:
 Univ Nacl Autonoma Mexico, Inst Quim, Mexico City 04510, DF, Mexico

Marcos M.-G.:
 Univ Nacl Autonoma Mexico, Inst Quim, Mexico City 04510, DF, Mexico
ISSN: 18715206
Editorial
BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
Tipo de documento: Article
Volumen: 14 Número: 3
Páginas: 459-465
WOS Id: 000331883600009
ID de PubMed: 24144199